154 related articles for article (PubMed ID: 29394701)
1. [Experience of Ramucirumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer in Our Hospital].
Hagino S; Miyata T; Sakamoto K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1559-1561. PubMed ID: 29394701
[TBL] [Abstract][Full Text] [Related]
2. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J; Yoshino T; Cohn AL; Obermannova R; Bodoky G; Garcia-Carbonero R; Ciuleanu TE; Portnoy DC; Van Cutsem E; Grothey A; Prausová J; Garcia-Alfonso P; Yamazaki K; Clingan PR; Lonardi S; Kim TW; Simms L; Chang SC; Nasroulah F;
Lancet Oncol; 2015 May; 16(5):499-508. PubMed ID: 25877855
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab].
Nakayasu Y; Yoshimatsu K; Yokomizo H; Osawa G; Yano Y; Nakayama M; Sakuma A; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2029-31. PubMed ID: 24394002
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Rectal Cancer with Unresectable Liver Metastasis Responding to Rechallenge with FOLFIRI].
Kamiya M; Yoneyama K; Doi Y; Shirai J; Suzuki Y; Hatori S; Yamada T; Sato T; Yamamoto N; Oshima T; Yukawa N; Yoshikawa T; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2277-2279. PubMed ID: 28133294
[TBL] [Abstract][Full Text] [Related]
5. [A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure].
Osawa G; Yoshimatsu K; Yokomizo H; Otani T; Yano Y; Itagaki H; Matsumoto A; Fujimoto T; Umehara A; Ogawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2526-8. PubMed ID: 21224628
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Simultaneous Laparoscopic Resection of Sigmoid Colon Cancer and Liver Metastases after Chemotherapy with Modified FOLFOX6 plus Panitumumab].
Terada I; Amaya K; Watanabe T; Terai S; Kawahara Y; Yamamoto S; Kaji M; Maeda K; Shimizu K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2166-8. PubMed ID: 26805299
[TBL] [Abstract][Full Text] [Related]
7. [A case of long-term survival following chemotherapy after laparoscopic resection of sigmoid colon cancer with multiple liver metastases].
Ohashi I; Arai I; Tamura C; Hayashi N; Inoue S; Wakasa T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1758-60. PubMed ID: 25731320
[TBL] [Abstract][Full Text] [Related]
8. [A case of sigmoid colon cancer with liver and ovarian metastases effectively treated by panitumumab after acquiring resistance to prior chemotherapy regimens].
Honda K; Hata Y; Ihara E; Tomita Y; Miyata S; Sumida Y; Ihara Y; Misawa T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1533-6. PubMed ID: 21918357
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of metastatic colorectal cancer in wild-type K-RAS effectively treated by panitumumab].
Ishiyama Y; Kotake M; Matsunaga M; Kitamura H; Yamamoto M; Inaki N; Kurokawa M; Bando H; Yamada T
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1567-70. PubMed ID: 23064074
[TBL] [Abstract][Full Text] [Related]
10. [A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab].
Horioka K; Kaku K; Jimi S; Oohata Y; Kamei T
Gan To Kagaku Ryoho; 2013 Mar; 40(3):397-9. PubMed ID: 23507607
[TBL] [Abstract][Full Text] [Related]
11. [Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection].
Mitsuhashi K; Matsusaka S; Mizunuma N; Ichimura T; Ozaka M; Ogura M; Shinozaki E; Suenaga M; Chin K; Fujimoto Y; Saiura A; Yamamoto N; Hatake K
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2203-7. PubMed ID: 21084828
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.
Yoshihiro T; Kusaba H; Makiyama A; Kobayashi K; Uenomachi M; Ito M; Doi Y; Mitsugi K; Aikawa T; Takayoshi K; Esaki T; Shimokawa H; Tsuchihashi K; Ariyama H; Akashi K; Baba E
Int J Clin Oncol; 2019 May; 24(5):508-515. PubMed ID: 30604155
[TBL] [Abstract][Full Text] [Related]
13. SPIRITT: A Randomized, Multicenter, Phase II Study of Panitumumab with FOLFIRI and Bevacizumab with FOLFIRI as Second-Line Treatment in Patients with Unresectable Wild Type KRAS Metastatic Colorectal Cancer.
Hecht JR; Cohn A; Dakhil S; Saleh M; Piperdi B; Cline-Burkhardt M; Tian Y; Go WY
Clin Colorectal Cancer; 2015 Jun; 14(2):72-80. PubMed ID: 25982297
[TBL] [Abstract][Full Text] [Related]
14. [A case of liver metastases from rectal cancer showed a complete response by FOLFIRI and bevacizumab chemotherapy].
Kuwada A; Nakamitsu A; Imamura Y; Kouyama M; Uekami S; Touge K; Taogoshi H; Fukuda Y; Daimaru H
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2937-40. PubMed ID: 21160275
[TBL] [Abstract][Full Text] [Related]
15. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
16. [A Case of a Patient with Rectum Cancer with Multiple Metastases, Who Was Able to Undergo Conversion Therapy Using Alternating mFOLFOX6 and FOLFIRI Regimens in Combination with Alternating Cetuximab and Bevacizumab].
O'hara H; Yamamoto H
Gan To Kagaku Ryoho; 2018 Nov; 45(11):1669-1672. PubMed ID: 30449861
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
Peeters M; Price TJ; Cervantes A; Sobrero AF; Ducreux M; Hotko Y; André T; Chan E; Lordick F; Punt CJ; Strickland AH; Wilson G; Ciuleanu TE; Roman L; Van Cutsem E; Tzekova V; Collins S; Oliner KS; Rong A; Gansert J
J Clin Oncol; 2010 Nov; 28(31):4706-13. PubMed ID: 20921462
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Chemotherapy with FOLFOXIRI plus Cetuximab for Liver Metastasis of Sigmoid Colon Cancer].
Saito A; Konishi K; Fukunaga M; Takiguchi N; Nakai S; Honda S; Yukimoto R; Okamoto A; Takeoka T; Matsuno H; Okada K; Ota H; Yokoyama S; Konishi M; Kobayashi K
Gan To Kagaku Ryoho; 2018 Mar; 45(3):507-509. PubMed ID: 29650920
[TBL] [Abstract][Full Text] [Related]
19. [A Case Report on a Successful Resection after FOLFIRI plus Cetuximab Therapy for Unresectable Colorectal Cancer with Multiple Liver Metastases].
Kanamori M; Kurumiya Y; Mizuno K; Sekoguchi E; Kobayashi S; Fukami Y; Kiriyama M; Aoyama H; Oiwa T; Miyamura K; Jinno T; Nakashima Y; Mori M
Gan To Kagaku Ryoho; 2017 May; 44(5):417-420. PubMed ID: 28536339
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
